EGFR methylation and outcome of patients with advanced colorectal cancer treated with cetuximab

EGFR methylation and outcome of patients with advanced colorectal cancer treated with cetuximab

Targeted therapy of metastatic colorectal cancer (mCRC) with monoclonal antibody anti-epidermal growth factor receptor (EGFR) agents, such as cetuximab (CTX) or panitumumab, is the treatment strategy of choice in patients characterised by a wild-type (wt) RAS gene status. However, despite selection...

Full description

Bibliographic Details
Main Authors: CHIADINI, ELISA, SCARPI, EMANUELA, PASSARDI, ALESSANDRO, CALISTRI, DANIELE, VALGIUSTI, MARTINA, SARAGONI, LUCA, ZOLI, WAINER, AMADORI, DINO, ULIVI, PAOLA
Format: Online
Language:English
Published: D.A. Spandidos 2015
Online Access:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4315084/

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4315084/

Similar Items